August 2026 FDA Recall Drug by Baxter Healthcare Corporation
D-0850-2026 - Presence of Particulate Matter

This Class I drug recall was voluntarily initiated by Baxter Healthcare Corporation on August 17, 2026 for the product Drug. The FDA reported the reason for recall as presence of particulate matter. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0850-2026

Reason for Recall
Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.
Initiated
08-17-2026
Reported
09-16-2026
Quantity
606 bags

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
99679
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Ongoing
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Baxter Healthcare Corporation
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
U.S. Nationwide.
Product Description About Product Description
Full technical description of the product.
Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporation Deerfield, IL, 60016, Made in USA, NDC 00338-0719-06

Batch or Lot Expiration Information

Lot# : Y495066, Exp. Date July 31, 2027